MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 63 filers reported holding MEI PHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $9 | +125.0% | 37,190 | +123.2% | 0.00% | – |
Q4 2022 | $4 | -99.9% | 16,661 | 0.0% | 0.00% | – |
Q3 2022 | $6,000 | -57.1% | 16,661 | -26.2% | 0.00% | – |
Q2 2022 | $14,000 | -41.7% | 22,569 | -41.9% | 0.00% | – |
Q1 2022 | $24,000 | -80.5% | 38,860 | -15.1% | 0.00% | -100.0% |
Q4 2021 | $123,000 | +846.2% | 45,780 | +827.3% | 0.00% | – |
Q3 2021 | $13,000 | -66.7% | 4,937 | -64.0% | 0.00% | -100.0% |
Q2 2021 | $39,000 | +14.7% | 13,723 | +36.5% | 0.00% | 0.0% |
Q1 2021 | $34,000 | -50.7% | 10,052 | -61.5% | 0.00% | -50.0% |
Q4 2020 | $69,000 | -81.1% | 26,108 | -77.7% | 0.00% | -50.0% |
Q3 2020 | $366,000 | +297.8% | 117,214 | +429.0% | 0.00% | 0.0% |
Q2 2020 | $92,000 | +318.2% | 22,158 | +66.1% | 0.00% | +100.0% |
Q3 2019 | $22,000 | -91.8% | 13,337 | -87.6% | 0.00% | -88.9% |
Q2 2019 | $268,000 | +1476.5% | 107,163 | +1795.7% | 0.02% | +1700.0% |
Q1 2019 | $17,000 | +1600.0% | 5,653 | +1666.6% | 0.00% | – |
Q3 2018 | $1,000 | -91.7% | 320 | -89.1% | 0.00% | -100.0% |
Q2 2018 | $12,000 | +500.0% | 2,935 | +176.1% | 0.00% | – |
Q1 2018 | $2,000 | -87.5% | 1,063 | -85.8% | 0.00% | -100.0% |
Q4 2017 | $16,000 | – | 7,468 | +7368.0% | 0.00% | – |
Q2 2017 | $0 | -100.0% | 100 | -97.3% | 0.00% | -100.0% |
Q1 2017 | $6,000 | +200.0% | 3,731 | +166.1% | 0.00% | – |
Q2 2016 | $2,000 | +100.0% | 1,402 | +42.5% | 0.00% | – |
Q1 2016 | $1,000 | -75.0% | 984 | -57.0% | 0.00% | -100.0% |
Q4 2015 | $4,000 | -60.0% | 2,287 | -62.7% | 0.00% | 0.0% |
Q2 2015 | $10,000 | +900.0% | 6,136 | +1945.3% | 0.00% | – |
Q1 2015 | $1,000 | -95.7% | 300 | -91.0% | 0.00% | -100.0% |
Q3 2014 | $23,000 | +666.7% | 3,326 | +729.4% | 0.00% | – |
Q2 2014 | $3,000 | -81.2% | 401 | -70.8% | 0.00% | -100.0% |
Q1 2014 | $16,000 | -51.5% | 1,374 | -67.1% | 0.00% | -66.7% |
Q4 2013 | $33,000 | +13.8% | 4,173 | +62.5% | 0.01% | +100.0% |
Q3 2013 | $29,000 | -31.0% | 2,568 | -56.1% | 0.00% | 0.0% |
Q2 2013 | $42,000 | – | 5,848 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TLS Advisors LLC | 2,010,285 | $490 | 2.42% |
Anson Funds Management LP | 10,617,959 | $2,586,535 | 0.43% |
NEA Management Company, LLC | 8,533,072 | $2,078,656 | 0.12% |
Boxer Capital, LLC | 2,913,091 | $709,629 | 0.04% |
Investmark Advisory Group LLC | 136,000 | $33,130 | 0.02% |
CARLSON CAPITAL L P | 1,180,000 | $287,448 | 0.02% |
Mesirow Financial Investment Management, Inc. | 20,486 | $4,990 | 0.02% |
Artal Group S.A. | 1,000,000 | $244 | 0.01% |
Annandale Capital, LLC | 100,000 | $24 | 0.01% |
ACADIAN ASSET MANAGEMENT LLC | 4,758,364 | $1,158 | 0.01% |